medroxyprogesterone has been researched along with Hyperlipemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Windler, E | 1 |
Ahrens, EH; Panveliwalla, D; Pertsemlidis, D | 1 |
Bagdade, JD; Bierman, EL; Hazzard, WR; Spiger, MJ | 1 |
1 review(s) available for medroxyprogesterone and Hyperlipemia
Article | Year |
---|---|
Modification of serum lipids and cardiovascular risk by estrogenic active compounds.
Topics: Aged; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Hyperlipidemias; Medroxyprogesterone; Menopause; Middle Aged; Risk Factors; Selective Estrogen Receptor Modulators | 1999 |
2 other study(ies) available for medroxyprogesterone and Hyperlipemia
Article | Year |
---|---|
Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man.
Topics: Bile; Bile Acids and Salts; Carbon Radioisotopes; Cholecystectomy; Cholecystography; Cholelithiasis; Cholesterol; Cholic Acids; Clofibrate; Contraceptives, Oral; Drug Combinations; Estrogens; Fasting; Feces; Female; Humans; Hyperlipidemias; Kinetics; Lipid Metabolism; Lipids; Lipoproteins; Liver Circulation; Male; Medroxyprogesterone; Phospholipids; Progesterone; Triglycerides | 1974 |
Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives.
Topics: Adult; Basal Metabolism; Body Weight; Contraceptives, Oral; Ethinyl Estradiol; Female; Heparin; Humans; Hyperlipidemias; Insulin; Lipoprotein Lipase; Medroxyprogesterone; Pregnancy; Triglycerides | 1969 |